The World Health Organization (WHO) on Friday announced that the Zika virus outbreak, linked to deformations in babies' heads and brains, no longer poses a world public health emergency, though it warned the epidemic remains a challenge.
The World Health Organization on Friday announced in an online press conference that the Zika virus outbreak no longer poses a world public health emergency.
--A new technique could help nearly double the precious few hours surgeons have to carry out lung transplants, raising hopes for saving more lives, said a study released Friday.
For the first time, a new drug given along with a cholesterol-lowering statin treatment has proved able to shrink plaque that is clogging arteries, potentially giving a way to undo some of the damage of heart disease, a study has found.
The number of people across the globe suffering from high blood pressure has almost doubled over the past four decades, with the biggest rise in south Asia and Africa, researchers said on Wednesday.
More than a dozen people in Sierra Leone were infected with Ebola, but showed no symptoms, suggesting that the massive and deadly West Africa epidemic was larger than previously thought, researchers said on Tuesday.
West Nile virus may be three times more deadly than previously thought, because many deaths associated with the mosquito-borne virus occur years after the initial infection, researchers said Monday.
A new study gives some reassurance to arthritis sufferers who want pain relief but are worried about side effects. It finds that Celebrex, a drug similar to ones withdrawn 12 years ago for safety reasons, is no riskier for the heart than some other prescription pain pills that are much tougher on the stomach.
Clean living can slash your risk for heart disease even if your genes are heavily stacked against you. A large study finds that people with the most inherited risk cut their chances of having a heart attack or other heart problems in half if they didn't smoke, ate well, exercised and stayed slim.
Top GlaxoSmithKline (GSK) executives have said the days of pharmaceutical companies paying doctors to educate their peers about a brand's products look set to change, with other big drugmakers ready to follow the firm's lead in reforming how medicine is marketed to health care professionals.